Bérangère Devalet

  • Belgium

  • 227 Citations
  • 8 h-Index
20132019
If you made any changes in Pure these will be visible here soon.

Research Output 2013 2019

  • 227 Citations
  • 8 h-Index
  • 13 Article
  • 11 Poster
  • 6 Conference contribution
  • 5 Review article
Filter
Conference contribution
2017
12 Downloads (Pure)

Stability of TGA Parameters in Patients Treated with Anticoagulants Using the Fully Automated ST-Genesia System

Douxfils, J., Nicolas, J-B., Larock, A-S., Devalet, B., Vandermeeren, Y., Gérard, V., Guldenpfennig, M., De Fays, K., Baudar, J. & Mullier, F., 2017, Research and practice in thrombosis and haemostasis: Abstracts of the XXVI Congress of the International Society on Thrombosis and Haemostasis, July 8–13, 2017. Vol. 1. p. 513-514 2 p.

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Open Access
File
2 Downloads (Pure)

The Impact of the Eculizumab on the Thrombogenicity Induced by Extracellular Vesicles in Paroxysmal Nocturnal Hemoglobinuria Patients

Wannez, A., Devalet, B., Bouvy, C., Bihin, B., Douxfils, J., Dogne, J-M. & Mullier, F., 2017, Research and practice in thrombosis and haemostasis: Abstracts of the XXVI Congress of the International Society on Thrombosis and Haemostasis, July 8–13, 2017. Vol. 1. p. 1083 1 p.

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Open Access
File
2016

Application of a clot based assay to measure the procoagulant activity of stored allogeneic red blood cell concentrates

Devalet, B., Wannez, A., Bailly, N., Alpan, L., Gheldof, D., Douxfils, J., Deneys, V., Bihin, B., Chatelain, B., Dogne, J-M., Chatelain, C. & Mullier, F., 13 May 2016, Abstracts of the 62nd Annual Meeting of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis May 25–28, 2016. p. 142 1 p. VAS26

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Open Access
2014

What is the best time sampling for the two direct oral anticoagulants (DOACs), dabigatran and rivaroxaban?

Douxfils, J., Baudar, J., Devalet, B., Samama, M. M., Chatelain, B., Dogne, J-M. & Mullier, F., 2014, Journal of Thrombosis and Haemostasis. 2014 Jun;12 Suppl 1:1-117.

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

2013

Dilute Russell Viper Venom Time: A Useful Assay for the Monitoring of Direct Oral Anticoagulants in Patients?

Douxfils, J., Tamigniau, A., Chatelain, B., Devalet, B., Wallemacq, P., Hjemdahl, P., Rönquist-Nii, Y., Mullier, F. & Dogne, J-M., 2013, Abstracts of the 21th Annual Meeting of the Belgian Society on Thrombosis and Haemostasis.

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

21 Downloads (Pure)

Is Dilute Russell’s Viper Venom Time a Useful Assay To Monitor Patients Treated By Rivaroxaban Or Dabigatran Etexilate?

Douxfils, J., Tamigniau, A., Chatelain, B., Devalet, B., Wallemacq, P., Hjemdahl, P., Rönquist-Nii, Y., Dogne, J-M. & Mullier, F., 2013, Blood 2013 122:3634; published ahead of print December 6, 2013.

Research output: Contribution in Book/Catalog/Report/Conference proceedingConference contribution

Open Access
File